- Trade options, futures, options on futures, stocks, ETFs
- $0 commission to close options
- Pro-grade platform and risk analysis tools
Finder makes money from featured partners, but editorial opinions are our own.
Advertiser disclosure
Teva Pharma Industries Ltd ADR is a drug manufacturers - specialty & generic business based in the US. Teva Pharma Industries Ltd ADR shares (TEVA) are listed on the NYSE and all prices are listed in US Dollars. Its last market close was $22.09 – an increase of 33.88% over the previous week. Teva Pharma Industries Ltd ADR employs 37,000 staff and has a trailing 12-month revenue of around $16.8 billion.
What's in this guide?
- TEVA shares summary
- Compare share dealing platforms
- Is TEVA stock a buy or sell?
- Stock performance over time
- Can I short TEVA shares?
- Are TEVA shares over-valued?
- Teva Pharma Industries Ltd ADR's financials
- How volatile are TEVA shares?
- Does Teva Pharma Industries Ltd ADR pay a dividend?
- Have TEVA shares ever split?
- Other common questions
Our top picks for where to buy Teva Pharma Industries Ltd ADR stock
- Trade $0 commission stocks & ETFs with as little as $1
- Earn up to $300 with qualifying deposits
- Discover new opportunities with Opto's AI-driven thematic investing system
- Theme and ETF screener
- Trade stocks, options, ETFs, mutual funds, alternative asset funds
- $0 commission on stocks, ETFs and options with no options contract fees
- Get up to $1,000 in stock when you fund a new account within 30 days
- Complimentary access to a financial planner
Probability of member receiving $1,000 is 0.028%
How to buy Teva Pharma Industries Ltd ADR stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – TEVA. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Teva Pharma Industries Ltd ADR stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.1 - 4 of 4
What is the Finder Score?
The Finder Score crunches 147 key metrics we collected directly from 18+ brokers and assessed each provider’s performance based on nine different categories, weighing each metric based on the expertise and insights of Finder’s investment experts. We then scored and ranked each provider to determine the best brokerage accounts.
We update our best picks as products change, disappear or emerge in the market. We also regularly review and revise our selections to ensure our best provider lists reflect the most competitive available.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Teva Pharma Industries Ltd ADR stock price (NYSE: TEVA)
Use our graph to track the performance of TEVA stocks over time.Teva Pharma Industries Ltd ADR shares at a glance
Information last updated 2024-12-19.
| Latest market close | $22.09 |
|---|---|
| 52-week range | $10.34 - $21.98 |
| 50-day moving average | $17.56 |
| 200-day moving average | $16.51 |
| Wall St. target price | $23.48 |
| PE ratio | N/A |
| Dividend yield | N/A |
| Earnings per share (TTM) | $-0.85 |
Is it a good time to buy Teva Pharma Industries Ltd ADR stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Teva Pharma Industries Ltd ADR price performance over time
Historical closes compared with the close of $21.31 from 2024-12-19
| 1 week (2024-12-13) | 29.15% |
|---|---|
| 1 month (2024-11-22) | 24.47% |
| 3 months (2024-09-20) | 21.70% |
| 6 months (2024-06-21) | 25.65% |
| 1 year (2023-12-21) | 101.23% |
|---|---|
| 2 years (2022-12-21) | 140.25% |
| 3 years (2021-12-21) | 155.82% |
| 5 years (2019-12-20) | 110.57% |
Is Teva Pharma Industries Ltd ADR stock undervalued or overvalued?
Valuing Teva Pharma Industries Ltd ADR stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Teva Pharma Industries Ltd ADR's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Teva Pharma Industries Ltd ADR's PEG ratio
Teva Pharma Industries Ltd ADR's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.2934. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Teva Pharma Industries Ltd ADR's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Teva Pharma Industries Ltd ADR's EBITDA
Teva Pharma Industries Ltd ADR's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $4.8 billion.
The EBITDA is a measure of a Teva Pharma Industries Ltd ADR's overall financial performance and is widely used to measure a its profitability.
Teva Pharma Industries Ltd ADR financials
| Revenue TTM | $16.8 billion |
|---|---|
| Operating margin TTM | 23.18% |
| Gross profit TTM | $7 billion |
| Return on assets TTM | 5.56% |
| Return on equity TTM | -17.52% |
| Profit margin | -5.72% |
| Book value | $5.35 |
| Market Capitalization | $24 billion |
TTM: trailing 12 months
Teva Pharma Industries Ltd ADR's environmental, social and governance track record
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Teva Pharma Industries Ltd ADR.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
Teva Pharma Industries Ltd ADR's total ESG risk score
Total ESG risk: 58.8
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Teva Pharma Industries Ltd ADR's overall score of 58.8 (as at 12/31/2018) is pretty weak – landing it in it in the 76th percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like Teva Pharma Industries Ltd ADR is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
Teva Pharma Industries Ltd ADR's environmental score
Environmental score: 77.02/100
Teva Pharma Industries Ltd ADR's environmental score of 77.02 puts it squarely in the 87th percentile of companies rated in the same sector. This could suggest that Teva Pharma Industries Ltd ADR is a laggard in its sector in terms of its environmental impact, and exposed to a greater level of risk.
Teva Pharma Industries Ltd ADR's social score
Social score: 47.2/100
Teva Pharma Industries Ltd ADR's social score of 47.2 puts it squarely in the 58th percentile of companies rated in the same sector. This could suggest that Teva Pharma Industries Ltd ADR is pretty average in terms of looking after its workforce and social impact.
Teva Pharma Industries Ltd ADR's governance score
Governance score: 65.26/100
Teva Pharma Industries Ltd ADR's governance score puts it squarely in the 81st percentile of companies rated in the same sector. That could suggest that Teva Pharma Industries Ltd ADR is a laggard in its sector in terms of responsible leadership, and exposed to a greater level of risk.
Teva Pharma Industries Ltd ADR's controversy score
Controversy score: 3/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. Teva Pharma Industries Ltd ADR scored a 3 out of 5 for controversy – a middle-of-the-table result reflecting that Teva Pharma Industries Ltd ADR hasn't always managed to keep its nose clean.
Environmental, social, and governance (ESG) summary
Teva Pharma Industries Ltd ADR was last rated for ESG on: 2019-01-01.
| Total ESG score | 58.8 |
|---|---|
| Total ESG percentile | 76.26 |
| Environmental score | 77.02 |
| Environmental score percentile | 87.16 |
| Social score | 47.2 |
| Social score percentile | 58.24 |
| Governance score | 65.26 |
| Governance score percentile | 80.64 |
| Level of controversy | 3 |
Teva Pharma Industries Ltd ADR share dividends
We're not expecting Teva Pharma Industries Ltd ADR to pay a dividend over the next 12 months.
Have Teva Pharma Industries Ltd ADR's shares ever split?
Teva Pharma Industries Ltd ADR's shares were split on a 2:1 basis on 30 June 2004 . So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Teva Pharma Industries Ltd ADR shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Teva Pharma Industries Ltd ADR shares which in turn could have impacted Teva Pharma Industries Ltd ADR's share price.
Teva Pharma Industries Ltd ADR share price volatility
Over the last 12 months, Teva Pharma Industries Ltd ADR's shares have ranged in value from as little as $10.34 up to $21.98. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Teva Pharma Industries Ltd ADR's is 0.868. This would suggest that Teva Pharma Industries Ltd ADR's shares are less volatile than average (for this exchange).
Teva Pharma Industries Ltd ADR overview
Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, Israel, and internationally. It offers generic medicines in various dosage forms, such as tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams; sterile products, hormones, high-potency drugs, and cytotoxic substances in parenteral and solid dosage forms; and generic products with medical devices and combination products. The company focuses on the central nervous system (CNS), respiratory, and oncology areas. It provides active pharmaceutical ingredients, as well as contract manufacturing services; and operates an out-licensing platform that offers a portfolio of products to other pharmaceutical companies. The company also offers BENDEKA and TREANDA injections for the treatment of chronic lymphocytic leukemia and indolent b-cell non-hodgkin's lymphoma; GRANIX; TRISENOX; LONQUEX; and TEVAGRASTIM/RATIOGRASTIM. In addition, it provides COPAXONE for the treatment of relapsing forms of multiple sclerosis; AJOVY for the preventive treatment of migraine in adults; AUSTEDO for the treatment of neurodegenerative and movement disorders associated with Huntington's disease and tardive dyskinesia; UZEDY for the treatment of schizophrenia; ProAir RespiClick inhalation powder; QVAR for treatment for asthma; BRALTUS, a long-acting muscarinic antagonist; CINQAIR/CINQAERO injection; DuoResp Spiromax, an inhaled corticosteroid and long-acting beta-agonist bronchodilator; and AirDuo RespiClick fluticasone propionate and salmeterol inhalation powder. The company offers its OTC products under SUDOCREM, NasenDuo, DICLOX FORTE, OLFEN Max, and FLEGAMINA brand names.
Frequently asked questions
nullWhat percentage of Teva Pharma Industries Ltd ADR is owned by insiders or institutions?
Currently 0.001% of Teva Pharma Industries Ltd ADR shares are held by insiders and 57.827% by institutions. How many people work for Teva Pharma Industries Ltd ADR?
Latest data suggests 37,000 work at Teva Pharma Industries Ltd ADR. When does the fiscal year end for Teva Pharma Industries Ltd ADR?
Teva Pharma Industries Ltd ADR's fiscal year ends in December. Where is Teva Pharma Industries Ltd ADR based?
Teva Pharma Industries Ltd ADR's address is: 124 Dvora HaNevi?a Street, Tel Aviv, Israel, 6944020 What is Teva Pharma Industries Ltd ADR's ISIN number?
Teva Pharma Industries Ltd ADR's international securities identification number is: US8816242098 What is Teva Pharma Industries Ltd ADR's CUSIP number?
Teva Pharma Industries Ltd ADR's Committee on Uniform Securities Identification Procedures number is: 881624209
More resources on Finder
More guides on Finder
-
Best Stocks for Beginners With Little Money to Invest
These are the stocks to buy when you don’t have much to spend.
-
Sweep Accounts
Check out our picks for the brokers with the best cash sweep rates on uninvested cash.
-
7 Best Day Trading Apps of 2024
These are the best day trading apps, according to Finder’s comprehensive analysis.
-
Today’s Best Brokerage Account Bonuses [Signup and Transfer Promos]
Explore the best bonuses for opening a new brokerage account.
-
5 best stock picking services of 2024
Compare the 5 best stock picking services, according to Finder’s analysis, and learn how to choose the best option for your needs.
-
5 Top Graphene Stocks to Invest in Today
We’ve rounded up stats on some of the most popular graphene stocks, along with information on how they compare and how to invest.
-
Ratings methodology for online brokers
Our star ratings for online brokerages are based on how they stack up in nine key categories.
-
How to invest in the S&P 500 in 2024
What you need to know about investing in the leading indicator for the overall US stock market.
-
How to Invest $10K
Maximize $10,000 with broker bonuses, IRA contribution matches, index funds, stocks, ladder CDs, hiring a financial advisor and more.
-
5 best ETFs for 2024
Check out the best-performing ETFs so far in 2024.
Ask a question